|
Volumn 6, Issue 8, 2005, Pages 546-
|
Proteasome inhibitor for treatment of multiple myeloma
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BORTEZOMIB;
DEXAMETHASONE;
PROTEASOME INHIBITOR;
ANTINEOPLASTIC ACTIVITY;
CANCER RELAPSE;
CHROMOSOME DELETION 13;
CLINICAL TRIAL;
DISEASE COURSE;
DISEASE SEVERITY;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG POTENCY;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
MULTIPLE MYELOMA;
NOTE;
PRIORITY JOURNAL;
SURVIVAL TIME;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
BORONIC ACIDS;
DRUG RESISTANCE, NEOPLASM;
HUMANS;
MULTIPLE MYELOMA;
PYRAZINES;
RECURRENCE;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
EID: 22944466739
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(05)70264-3 Document Type: Note |
Times cited : (6)
|
References (0)
|